ONTOLOGY REPORT - ANNOTATIONS
Term: ceruletide
Accession: CHEBI:59219
browse the term
Definition: A decapeptide comprising 5-oxoprolyl, glutamyl, aspartyl, O-sulfotyrosyl, threonyl, glycyl, tryptopyl, methionyl, aspartyl and phenylalaninamide residues in sequence. Found in the skins of certain Australian amphibians, it is an analogue of the gastrointestinal peptide hormone cholecystokinin and stimulates gastric, biliary, and pancreatic secretion. It is used in cases of paralysis of the intestine (paralytic ileus) and as a diagnostic aid in pancreatic malfunction.
Synonyms: exact_synonym: 5-oxo-L-prolyl-L-glutaminyl-L-alpha-aspartyl-O-sulfo-L-tyrosyl-L-threonylglycyl-L-tryptophyl-L-methionyl-L-alpha-aspartyl-L-phenylalaninamide
related_synonym: C58H73N13O21S2; InChI=1S/C58H73N13O21S2/c1-29(72)49(71-57(87)40(23-31-12-14-33(15-13-31)92-94(89,90)91)68-56(86)43(26-48(78)79)69-52(82)37(16-18-44(59)73)65-51(81)36-17-19-45(74)63-36)58(88)62-28-46(75)64-41(24-32-27-61-35-11-7-6-10-34(32)35)54(84)66-38(20-21-93-2)53(83)70-42(25-47(76)77)55(85)67-39(50(60)80)22-30-8-4-3-5-9-30/h3-15,27,29,36-43,49,61,72H,16-26,28H2,1-2H3,(H2,59,73)(H2,60,80)(H,62,88)(H,63,74)(H,64,75)(H,65,81)(H,66,84)(H,67,85)(H,68,86)(H,69,82)(H,70,83)(H,71,87)(H,76,77)(H,78,79)(H,89,90,91)/t29-,36+,37+,38+,39+,40+,41+,42+,43+,49+/m1/s1; InChIKey=YRALAIOMGQZKOW-HYAOXDFASA-N; [H][C@](NC(=O)[C@H](Cc1ccc(OS(O)(=O)=O)cc1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCC(=O)N1)([C@@H](C)O)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O; caerulein; cerulein; ceruletida; ceruletidum
xref_casrn: 17650-98-5
xref: Beilstein:5422487 "Beilstein Registry Number"; ChEMBL:775306 "ChEMBL COMPOUND"; ChemIDplus:17650-98-5 "CAS Registry Number"; DrugBank:DB00403 "DrugBank"; KEGG DRUG:D03442 "KEGG DRUG"
xref_mesh: MESH:D002108
xref: Wikipedia:Ceruletide "Wikipedia"
ceruletide
G
Alb
albumin
decreases expression
EXP
14
19,126,935
19,142,214
RGD:6480464
CTD
G
Bdkrb1
bradykinin receptor B1
increases expression
ISO
6
129,760,129
129,762,545
RGD:6480464
CTD
G
Bdkrb2
bradykinin receptor B2
increases expression
ISO
6
129,744,781
129,748,851
RGD:6480464
CTD
G
Casp3
caspase 3
multiple interactions
EXP
16
48,944,226
48,962,420
RGD:6480464
CTD
G
Casp3
caspase 3
multiple interactions
EXP
16
48,944,226
48,962,420
RGD:6480464
CTD
G
Casp8
caspase 8
multiple interactions
EXP
9
57,389,353
57,437,803
RGD:6480464
CTD
G
Casp9
caspase 9, apoptosis-related cysteine peptidase
multiple interactions
EXP
5
160,704,234
160,721,796
RGD:6480464
CTD
G
Ccl2
chemokine (C-C motif) ligand 2
multiple interactions
ISO
10
70,256,263
70,258,061
RGD:6480464
CTD
G
Ccl2
chemokine (C-C motif) ligand 2
increases expression
ISO
10
70,256,263
70,258,061
RGD:6480464
CTD
G
Ccl2
chemokine (C-C motif) ligand 2
increases expression
ISO
10
70,256,263
70,258,061
RGD:6480464
CTD
G
Cxcl1
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)
increases expression
ISO
14
18,690,339
18,692,118
RGD:6480464
CTD
G
Cxcl1
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)
multiple interactions
ISO
14
18,690,339
18,692,118
RGD:6480464
CTD
G
Cxcl1
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)
increases expression
ISO
14
18,690,339
18,692,118
RGD:6480464
CTD
G
Cxcl1
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)
multiple interactions
ISO
14
18,690,339
18,692,118
RGD:6480464
CTD
G
Icam1
intercellular adhesion molecule 1
increases expression
ISO
8
20,040,177
20,051,939
RGD:6480464
CTD
G
Icam1
intercellular adhesion molecule 1
multiple interactions
ISO
8
20,040,177
20,051,939
RGD:6480464
CTD
G
Il1b
interleukin 1 beta
increases expression
ISO
3
116,964,422
116,970,867
RGD:6480464
CTD
G
Il1b
interleukin 1 beta
increases expression
EXP
3
116,964,422
116,970,867
RGD:6480464
CTD
G
Il6
interleukin 6
increases expression
ISO
4
456,799
461,376
RGD:6480464
CTD
G
Il6
interleukin 6
multiple interactions
ISO
4
456,799
461,376
RGD:6480464
CTD
G
Jun
jun proto-oncogene
increases expression
ISO
5
115,358,166
115,361,259
RGD:6480464
CTD
G
Jun
jun proto-oncogene
multiple interactions
ISO
5
115,358,166
115,361,259
RGD:6480464
CTD
G
Mpo
myeloperoxidase
increases expression
ISO
10
76,085,872
76,097,012
RGD:6480464
CTD
G
Mpo
myeloperoxidase
multiple interactions
ISO
10
76,085,872
76,097,012
RGD:6480464
CTD
G
Pparg
peroxisome proliferator-activated receptor gamma
multiple interactions
ISO
4
151,492,220
151,617,331
RGD:6480464
CTD
G
Ptgs2
prostaglandin-endoperoxide synthase 2
increases expression
EXP
13
64,427,288
64,432,978
RGD:6480464
CTD
G
Ripk1
receptor (TNFRSF)-interacting serine-threonine kinase 1
increases cleavage
EXP
17
37,183,591
37,216,533
RGD:6480464
CTD
G
Tnf
tumor necrosis factor
multiple interactions
EXP
20
3,661,000
3,663,618
RGD:6480464
CTD
G
Tnf
tumor necrosis factor
increases expression
EXP
20
3,661,000
3,663,618
RGD:6480464
CTD
G
Tnf
tumor necrosis factor
increases expression
EXP
20
3,661,000
3,663,618
RGD:6480464
CTD
G
Tnf
tumor necrosis factor
multiple interactions
EXP
20
3,661,000
3,663,618
RGD:6480464
CTD
G
Xiap
X-linked inhibitor of apoptosis
increases degradation
EXP
X
3,011,520
3,047,798
RGD:6480464
CTD
Term paths to the root one longest all shortest one shortest all one shortest and longest all longest